[1] |
Liu Juxiu, Zhang Jianhua, Wen Junjun, Jiang Xiaoshuang.
Analysis and trend prediction of Mycobacterium tuberculosis drug resistance in Jilin City
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 348-354.
|
[2] |
Wang Xueyu, Wang Yujin, Chu Naihui, Kang Wanli, Nie Wenjuan.
A preliminary study on the enhanced in vivo exposure of sudapyridine in Mycobacterium abscessus-infected rats with the co-administration of clofazimine or clarithromycin
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 150-157.
|
[3] |
Shi Lulu, Jing Hui, Liang Min, Li Xuezheng.
Analysis of clinical results of blood concentration detection of antituberculosis drugs by liquid chromatography-tandem mass spectrometry
[J]. Chinese Journal of Antituberculosis, 2024, 46(8): 886-891.
|
[4] |
Ge Fei, Zhu Hui, Cheng Kai, Lu Yu, Xu Jian.
Study on the determination of isoniazid and its metabolites concentration in plasma by high-performance liquid chromatography-mass spectrometry
[J]. Chinese Journal of Antituberculosis, 2024, 46(5): 549-556.
|
[5] |
Chen Daiquan, Lin Shufang, Zhou Yinfa, Chen Kun, Dai Zhisong.
Patient delay and related factors among tuberculosis patient in Fujian Province, 2010—2019
[J]. Chinese Journal of Antituberculosis, 2023, 45(1): 96-103.
|
[6] |
XIE Li, ZHU Hui, GAO Jing-tao, LIU Zhong-quan, MA Li-ping, ZHANG Li-qun, GE Qi-ping, NIE Li-hui, KONG Zhong-shun, WU Xiao-guang, LIU Rong-mei, CHEN Hong-mei, SONG Yan-hua, LI Qiang, LYU Zi-zheng, LIU Yu-hong, LU Yu, PANG Yu, GAO Meng-qiu.
Changes of plasma concentration of bedaquiline during the treatment of drug-resistant pulmonary tuberculosis and its assocation with QTc interval prolongation
[J]. Chinese Journal of Antituberculosis, 2022, 44(3): 219-226.
|
[7] |
Beijing Chest Hospital, Capital Medical University, Editorial Board of Chinese Journal of Antituberculosis.
Expert consensus on the therapeutic drug monitoring of anti-tuberculosis drugs
[J]. Chinese Journal of Antituberculosis, 2021, 43(9): 867-873.
|
[8] |
LIN Jian, LIN Shu-fang, DAI Zhi-song, ZHAO Yong, ZHOU Yin-fa, ZHANG Tian-lin, WEI Shu-zhen.
Analysis of the drug resistance surveillance results of Mycobacterium tuberculosis in Fujian Province from 2016 to 2019
[J]. Chinese Journal of Antituberculosis, 2021, 43(9): 924-928.
|
[9] |
ZHOU Yin-fa, LIN Shu-fang, DAI Zhi-song, Wei Shu-zhen, CHEN Dai-quan.
Temporal-spatial distribution of pulmonary tuberculosis in Fujian Province during 2011—2020
[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 853-856.
|
[10] |
WANG Le-le, YANG Song, TANG Shen-jie.
A review of application of therapeutic drug monitoring in tuberculosis treatment
[J]. Chinese Journal of Antituberculosis, 2021, 43(3): 285-290.
|
[11] |
ZHANG Pei-ze, ZHENG Jun-feng, CAO Wei-peng, WANG Yu-xiang, CHEN Tao, FU Liang, DENG Guo-fang.
Study of the serum concentration at two time points after taking rifampicin
[J]. Chinese Journal of Antituberculosis, 2020, 42(5): 493-497.
|
[12] |
LIN Jian, LIN Shu-fang, DAI Zhi-song, ZHAO Yong, WEI Shu-zhen, ZHOU Yin-fa.
Study on the distribution and epidemiological characteristics of non-tuberculous mycobacterium strains in Fujian Province
[J]. Chinese Journal of Antituberculosis, 2020, 42(5): 518-522.
|
[13] |
Ming-wu LI,Ming-hong LAI,Meng MA,Rong WAN,Yuan XU,Chao-mei DU.
Analysis on the monitoring results of plasma-drug concentration of rifampicin in different dosage forms
[J]. Chinese Journal of Antituberculosis, 2019, 41(6): 645-649.
|
[14] |
Jun ZHOU,Xiao-hui LYU,Xiu-qi ZHENG,Chao-gang XIONG,Yuan ZHAO,Li-yun DANG.
Comparative analysis of the adjustment success ratio of plasma drug concentration of three anti-tubercular drugs
[J]. Chinese Journal of Antituberculosis, 2018, 40(9): 969-972.
|
[15] |
Shao-chen GUO,Hui ZHU,Chao GUO,Bin WANG,Zhong-quan LIU,Jian XU,Lei FU,Xiao-you CHEN,Yu LU.
Analysis of plasma concentrations of first-line anti-tuberculosis drugs in 909 tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2018, 40(7): 744-749.
|